PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-762

Are you saying they are outright lying?

I say they are in a similar situation to Cochlear was at a similar stage - lack of muny complicated by both internal factors - the originality and technical complexity of the science, and outside factors like legacy patent rights and a world that has gone to the edge of the precipice. Actually Cochlear was in a far worse situation at this stage: Their tech was first developed in an Aussie uni and they worked hard to make it technically a commercial proposition (just as is happening with PAA's mpl project) but they were having great trouble raising interest on the Aussie share market after an initial splash and they were on the verge of being sold off to overseas interests for a fistful of dollars like far too many Aussie innovations have been. Fortunately a local "white knight" took a gamble by backing them and "the rest is history".

Creating history is usually a very risky proposition. And it takes endurance. Do you think creating the first wide purpose,fourth generation mTOR drug IN THE WORLD, and perhaps the first one to really deliver the benefits promised by the last thirty years of mTOR scientific research around the world, was going to be a walk in the park on a sunny afternoon? Takes BALLS to do these things but the winingers will whinge.